论文部分内容阅读
目的 :研究慢性阻塞性肺疾病运用痰热清联合头孢呋辛钠治疗的临床效果。方法 :选择我院收治的65例慢性阻塞性肺疾病患者为研究对象,根据治疗方案将其分为两组,其中给予对照组痰热清治疗,而观察组则运用痰热清和头孢呋辛钠联合治疗,比较两组疗效。结果 :与对照组相比,观察组的胸片恢复正常、体温恢复正常以及临床症状缓解时间均较短,组间比较差异有统计学意义(P<0.05)。结论 :临床上运用痰热清和头孢呋辛钠对慢性阻塞性肺疾病患者进行联合治疗,能够明显改善患者的呼吸困难症状,并且缩短治疗时间,获得较好的疗效。
Objective: To study the clinical effect of using Tanreqing combined with cefuroxime sodium on chronic obstructive pulmonary disease. Methods: Sixty-five patients with chronic obstructive pulmonary disease who were treated in our hospital were selected as study subjects. They were divided into two groups according to the treatment regimen, of which the control group was given Tanreqing treatment while the observation group was treated with Tanreqing and cefuroxime sodium Combination therapy, the two groups were compared. Results: Compared with the control group, the chest radiograph returned to normal, the body temperature returned to normal, and the clinical symptom relief time was shorter. The differences between the two groups were statistically significant (P <0.05). Conclusion: The clinical application of Tanreqing and cefuroxime sodium in patients with COPD can significantly improve the patients’ symptoms of dyspnea, shorten the treatment time and obtain better curative effect.